CORONARY ARTERY DISEASE Original Studies Impact of Severity of Renal Dysfunction on Determinants of In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention
暂无分享,去创建一个
A. Jeremias | S. Naidu | R. Shlofmitz | S. Brener | P. Parikh | L. Gruberg | K. Marzo | T. Pappas | Puja Parikh | Fabio V. Lima | Srihari S. Naidu | K. Marzo | Kevin P. Marzo | Kevin P. Marzo
[1] A. Jeremias,et al. Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention. , 2011, The American journal of cardiology.
[2] M. Flather,et al. Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. , 2011, Journal of the American Society of Nephrology : JASN.
[3] O. Morel,et al. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. , 2011, Journal of the American College of Cardiology.
[4] David Dai,et al. Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. , 2009, JAMA.
[5] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[6] R. Califf,et al. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. , 2008, American heart journal.
[7] Matthew J Price,et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. , 2008, European heart journal.
[8] J. Ivanov,et al. Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention. , 2008, The American journal of cardiology.
[9] David L. Brown,et al. The impact of advanced chronic kidney disease on in‐hospital mortality following percutaneous coronary intervention for acute myocardial infarction , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[10] N. Weissman,et al. Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. , 2005, The American journal of cardiology.
[11] H. Krumholz,et al. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. , 2003, Journal of the American College of Cardiology.
[12] A. Jacobs,et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. , 2003, The American journal of cardiology.
[13] Eric J Topol,et al. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction. , 2002, American heart journal.
[14] G. Stone,et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[15] G. Stone,et al. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. , 2001, The American journal of cardiology.
[16] I. Palacios,et al. Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. , 2001, The American journal of cardiology.
[17] G. Dangas,et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.
[18] D. Baim,et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. , 2000, The American journal of cardiology.
[19] W. O’Neill,et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.
[20] M. Pencina,et al. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. , 2009, JACC. Cardiovascular interventions.
[21] B. Kasiske,et al. Excerpts from the United States Renal Data System 2007 annual data report. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.